DYN FY 2016 Earnings — Dyne Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

DYNDyne Therapeutics, Inc.

$3B

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1.4B+62.2% YoY

Gross Profit

-$915M-67.0% margin

Operating Income

-$640M-46.9% margin

Net Income

-$1.2B-90.8% margin

EPS (Diluted)

$-9.61

Cash Flow

Operating Cash Flow

$676M

Free Cash Flow

$350M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$13.1B

Total Liabilities

$11.0B

Stockholders' Equity

$2.0B

Cash & Equivalents

$1.8B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.4B	$842M	+62.2%
Gross Profit	-$915M	-$1.2B	+22.8%
Operating Income	-$640M	$64M	-1100.0%
Net Income	-$1.2B	$50M	-2580.0%